<DOC>
	<DOC>NCT02767817</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of injectable collagen scaffold combined with Mesenchymal stem cells (MSCs) transplantation in patients with brain injury.</brief_summary>
	<brief_title>Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>1. Male or female，3575 years old. 2. The surgery time should be &gt; 6 hours after symptom onset. 3. Glasgow coma score (GCS) was 915. 4. CT diagnosis of intracerebral hemorrhage (2540 ml), except for patients with signs of craniotomy to remove the hematoma. 5. Signed informed consent obtained from the patient or patient's legally authorized representative. 1. Glasgow coma scale of &lt;8. 2. Patients suffering severe heart failure, severe lung disease, uremia, cirrhosis, endstage cancer, coagulation disorders, stroke sequela. 3. Asphyxia, cardiac arrest or successful cardiopulmonary resuscitation before hospitalization. 4. Lactating or pregnant woman. 5. Refuse to sign informed content.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>